Zhejiang Huahai Pharmaceutical Co., Ltd. Class A · SSE:600521
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A shareholders
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A on 6ix: holders from US fund reports. Largest: Vanguard Total International Stock Index Fund, Vanguard Emerging Markets Stock Index Fund and Emerging Markets Core Equity 2 Portfolio. Each with its filing.
| Holder | Shares | % of Zhejiang Huahai Pharmaceutical Co., Ltd. Class A | Change | As of |
|---|---|---|---|---|
| Vanguard Total International Stock Index Fund | 1.46M | no change | Jul 31, 2026 | |
| Vanguard Emerging Markets Stock Index Fund | 1.41M | no change | Jul 31, 2026 | |
| Emerging Markets Core Equity 2 Portfolio | 297K | −156K | Jul 31, 2026 | |
| WisdomTree Emerging Markets SmallCap Dividend Fund | 277K | −3,000 | Jun 30, 2026 | |
| Vanguard Ftse All-World Ex-Us Index Fund | 266K | +47,000 | Jul 31, 2026 | |
| Dimensional Emerging Markets Value Fund | 248K | new | Jul 31, 2026 | |
| Schwab Emerging Markets Equity ETF | 140K | no change | May 31, 2026 | |
| Dimensional Emerging Markets Core Equity 2 ETF | 104K | +9,200 | Jul 31, 2026 | |
| Dimensional Emerging Core Equity Market ETF | 90,500 | −9,000 | Jul 31, 2026 | |
| Dimensional World ex. U.S. Core Equity 2 ETF | 79,610 | no change | Jul 31, 2026 |
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A insider trades